Consistently, our studies indicated that while FL118 shows excellent anti-sarcoma tumor activity (Fig. 8), FL118 exhibits selective toxicity against the AR−/lo LAPC9-AI vs. AR+ LAPC9-AD PCa cells in PDAC-derived organoids (Fig. 9). The gene discussed is AR; the disease is posterior cortical atrophy.